Brief: Natco Pharma Dec-Quarter Consol Net Profit 1.52 Billion Rupees
Feb 12 (Reuters) - Natco Pharma Ltd NATP.NS: DEC-QUARTER CONSOL NET PROFIT 1.52 BILLION RUPEES DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 6.47 BILLION RUPEES RE-APPOINTMENT OF RAJEEV NANNAPANENI AS CEO DECLARED DIVIDEND OF RS. 1.50 RUPEES PER SHARE RE-APPOINTMENT OF VENKAIAH CHOWDARY NANNAPANENI AS CHAIRMAN & MANAGING DIRECTOR Further company coverage: NATP.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees